Old Web
English
Sign In
Acemap
>
authorDetail
>
Julie Tillon
Julie Tillon
Internal medicine
Medicine
Oncology
Chemotherapy
Adverse effect
5
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study).
2009
Journal of Thoracic Oncology
A. Vergnenegre
Julie Tillon
R. Corre
Fabrice Barlesi
H Berard
Jean-Marc Vernejoux
Hervé Le Caer
P. Fournel
Benoît Marin
C. Chouaid
Show All
Source
Cite
Save
Citations (8)
P3-153: Uptaded analysis of a randomized phase II trial of early change of a chemotherapeutic doublet versus four cycles of chemotherapy in avanced non small cell lung cancer (NSCLC): the 03:01 Groupe Français de Pneumo–Cancérologie (GFPC) study
2007
Journal of Thoracic Oncology
A. Vergnenegre
C. Chouaid
R. Corre
Fabrice Barlesi
H Berard
Jean-Marc Vernejoux
Hervé Le Caer
Pierre Fournel
Benoît Marin
Julie Tillon
Show All
Source
Cite
Save
Citations (0)
A randomized phase II trial of early change of a chemotherapeutic doublet compared to four cycles of chemotherapy in advanced non-small cell lung cancer (NSCLC): The 03-01 Groupe Francais de Pneumo-Cancerologie (GFPC) study
2007
Journal of Clinical Oncology
A. Vergnenegre
R. Corre
Fabrice Barlesi
H Berard
Jean-Marc Vernejoux
H. Le Caer
P. Fournel
J.Y. Delhoume
D. Arpin
P. Thomas
Julie Tillon
Show All
Source
Cite
Save
Citations (0)
1